Sleep Extension and Blood Pressure

Sleep Extension Clinical Trial

Official title: Lowering Blood Pressure by Sleep Extension: a Randomized, Controlled Trial

Status Completed

Clinical Trial Summary

Emerging evidence suggests that approximately 30% of the US adult population sleeps less than 7 hours per night, and those who do exhibit 20-52% enhanced risk to develop cardiovascular diseases and particularly hypertension. Since sleep curtailment is largely voluntary, sleep deficiency can be corrected and its detrimental health consequences potentially reversed. The purpose of the present proposal is to investigate the cardiovascular and metabolic effects of sleep extension in prehypertensive and stage 1 hypertensive subjects who report habitual short sleep.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Sleep Extension

• NCT number: NCT02929810
• Study type: Interventional
• Source: Mayo Clinic
• Status: Completed
• Phase: N/A
• Start date: October 2016
• Completion date: September 7, 2023